06:40 AM EST, 02/05/2025 (MT Newswires) -- Bio-Techne ( TECH ) reported fiscal Q2 adjusted earnings Wednesday of $0.42 per diluted share, up from $0.40 a year earlier.

Analysts polled by FactSet expected $0.39.

Net sales for the quarter ended Dec. 31 were $297 million, up from $272.6 million a year earlier.

Analysts surveyed by FactSet expected $285.8 million.

The company's shares were up nearly 6% in recent premarket activity.

Price: 76.79, Change: +4.24, Percent Change: +5.8